Amir Tamiz PhD

National Institute of Neurological Disorders and Stroke, Division of Translational Research

Dr. Tamiz is an Associate Director at the National Institute of Neurological Disorders and Stroke (NINDS) and the Director of the Division of Translational Research (DTR). Dr. Tamiz oversees funding and resource programs for academic and industry researchers to accelerate basic research findings towards patient use for neurological disorders and stroke. He directs variety of notable programs including Neurotherapeutics Discovery and Development, Small Business and Epilepsy Therapy Screening that support the design, implementation, and management of research activities critical to translational challenges in the treatment of neurological disease and stroke. He joined NINDS/NIH in 2012, assuming increasing responsibilities including directing the NIH Blueprint Neurotherapeutics network (BPN) and Innovation Grants to Nurture Initial Translational Efforts (IGNITE). Dr. Tamiz was responsible for creating and launching the IGNITE program intended to create a more contiguous source of support from discovery to preclinical development. Prior to joining NIH, Dr. Tamiz had held scientific and management positions in research and development of therapeutic programs at Corvas International (acquired by Dendreon), CovX (now part of Pfizer), and Alba Therapeutics. Dr. Tamiz received his Ph.D. at University of Oregon and conducted postdoctoral research at the Department of Neuroscience at Georgetown University Medical Center.